| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |